Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Non-cash Items (2016 - 2025)

Historic Non-cash Items for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to $4.0 million.

  • Regenxbio's Non-cash Items fell 4006.66% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 4006.66%. This contributed to the annual value of $6.8 million for FY2024, which is 248.18% down from last year.
  • Latest data reveals that Regenxbio reported Non-cash Items of $4.0 million as of Q3 2025, which was down 4006.66% from $737000.0 recorded in Q2 2025.
  • In the past 5 years, Regenxbio's Non-cash Items registered a high of $74.1 million during Q3 2021, and its lowest value of $737000.0 during Q2 2025.
  • Over the past 5 years, Regenxbio's median Non-cash Items value was $7.4 million (recorded in 2025), while the average stood at $19.3 million.
  • As far as peak fluctuations go, Regenxbio's Non-cash Items soared by 197039.93% in 2021, and later tumbled by 9020.95% in 2022.
  • Over the past 5 years, Regenxbio's Non-cash Items (Quarter) stood at $41.1 million in 2021, then crashed by 61.62% to $15.8 million in 2022, then crashed by 55.58% to $7.0 million in 2023, then decreased by 2.48% to $6.8 million in 2024, then crashed by 42.07% to $4.0 million in 2025.
  • Its Non-cash Items was $4.0 million in Q3 2025, compared to $737000.0 in Q2 2025 and $7.4 million in Q1 2025.